Abstract
BackgroundThe immune suppression of myeloid cells and lymphocytes within the tumor microenvironment (TME) limits efficacy of checkpoint inhibitors. LILRB1 (ILT2) and LILRB2 (ILT4) are inhibitory receptors on immune cells that...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
